Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Clinical Data
Pharma
Roivant eyes Humira's throne in NIU after Lisraya ph. 3 win
With the ink barely dry on Lisraya’s first approval, Roivant is wasting little time making the case for a larger immune-mediated kingdom for the drug.
Fraiser Kansteiner
Oct 22, 2026 8:04am
Amgen, AZ eye Tezspire expansion after detailed EoE ph. 3 win
Oct 20, 2026 9:00am
Lilly says it's setting 'higher bar' in IBD with Omvoh post-hoc
Oct 15, 2026 11:00am
BMS is augmenting Zenbexus' efficacy profile in multiple myeloma
Oct 8, 2026 2:25pm
Argenx calls it quits on Vyvgart Hytrulo Sjögren's disease trial
Oct 8, 2026 10:44am
ViiV girds data package for Cabenuva in competitive HIV market
Oct 6, 2026 10:59am